Zobrazeno 1 - 10
of 279
pro vyhledávání: '"Michiel G H Betjes"'
Autor:
Yen-Ling Chiu, Kai-Hsiang Shu, Feng-Jung Yang, Tzu-Ying Chou, Ping-Min Chen, Fang-Yun Lay, Szu-Yu Pan, Cheng-Jui Lin, Nicolle H R Litjens, Michiel G H Betjes, Selma Bermudez, Kung-Chi Kao, Jean-San Chia, George Wang, Yu-Sen Peng, Yi-Fang Chuang
Publikováno v:
Immunity & Ageing, Vol 15, Iss 1, Pp 1-10 (2018)
Abstract Background Patients with end-stage renal disease (ESRD) exhibit a premature aging phenotype of the immune system. Nevertheless, the etiology and impact of these changes in ESRD patients remain unknown. Results Compared to healthy individuals
Externí odkaz:
https://doaj.org/article/c485f57a0a79416ea4172e2d98201066
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0228096 (2020)
BACKGROUND:The hypothesis was tested that parameters of an aged T-cell compartment associate with the risk for late rejection after kidney transplantation. METHODS:Recipients of a kidney transplant in the period 2007-2013 were (N = 365) were included
Externí odkaz:
https://doaj.org/article/f7bc69d3bdf346c5aea8a2f74a28f544
Autor:
Kasia A Sablik, Marian C Clahsen-van Groningen, Dennis A Hesselink, Teun van Gelder, Michiel G H Betjes
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0196552 (2018)
Chronic active antibody mediated rejection (c-aABMR) is a major cause of long-term kidney allograft loss. It is hypothesized that frequent sub-therapeutic exposure to immunosuppressive drugs, in particular tacrolimus (Tac), is a risk factor for the d
Externí odkaz:
https://doaj.org/article/7cbe0369a59f4e5fa97a40ba68b60c46
Autor:
Jeffrey A Lafranca, Mark van Bruggen, Hendrikus J A N Kimenai, Thi C K Tran, Türkan Terkivatan, Michiel G H Betjes, Jan N M IJzermans, Frank J M F Dor
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153460 (2016)
BACKGROUND:Whether vascular multiplicity should be considered as contraindication and therefore 'extended donor criterion' is still under debate. METHODS:Data from all live kidney donors from 2006-2013 (n = 951) was retrospectively reviewed. Vascular
Externí odkaz:
https://doaj.org/article/01777331e48b4d698452cef11e601a96
Autor:
Burç Dedeoglu, Ruud W J Meijers, Mariska Klepper, Dennis A Hesselink, Carla C Baan, Nicolle H R Litjens, Michiel G H Betjes
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150826 (2016)
End-stage renal disease patients have a dysfunctional, prematurely aged peripheral T-cell system. Here we hypothesized that the degree of premature T-cell ageing before kidney transplantation predicts the risk for early acute allograft rejection (EAR
Externí odkaz:
https://doaj.org/article/1d8694267a5b45b7bfade1e593398cf2
Autor:
Sayed M Habib, Alferso C Abrahams, Mario R Korte, Robert Zietse, Lisette L de Vogel, Walther H Boer, Amélie Dendooven, Marian C Clahsen-van Groningen, Michiel G H Betjes
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0120174 (2015)
Encapsulating peritoneal sclerosis (EPS) is a severe complication of peritoneal dialysis (PD). Previously, it has been shown that infiltrating CD4-positive T cells and M2 macrophages are associated with several fibrotic conditions. Therefore, the cha
Externí odkaz:
https://doaj.org/article/90256b57ddf049d78e07a0b3e63bfdd5
Autor:
Alferso C Abrahams, Sayed M Habib, Amélie Dendooven, Bruce L Riser, Jan Willem van der Veer, Raechel J Toorop, Michiel G H Betjes, Marianne C Verhaar, Christopher J E Watson, Tri Q Nguyen, Walther H Boer
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e112050 (2014)
IntroductionEncapsulating peritoneal sclerosis (EPS) is a devastating complication of peritoneal dialysis (PD). The pathogenesis is not exactly known and no preventive strategy or targeted medical therapy is available. CCN2 has both pro-fibrotic and
Externí odkaz:
https://doaj.org/article/fc8d2500790e4b3380c87aa87f51bc20
Autor:
Joerg Latus, Sayed M Habib, Daniel Kitterer, Mario R Korte, Christoph Ulmer, Peter Fritz, Simon Davies, Mark Lambie, M Dominik Alscher, Michiel G H Betjes, Stephan Segerer, Niko Braun, European EPS study group
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e106511 (2014)
BackgroundEncapsulating peritoneal sclerosis (EPS) commonly presents after peritoneal dialysis has been stopped, either post-transplantation (PT-EPS) or after switching to hemodialysis (classical EPS, cEPS). The aim of the present study was to invest
Externí odkaz:
https://doaj.org/article/5a1fae7c5e3b4488b9e8f18b32b5dcb4
Autor:
Gideon Post Hospers, Wesley J. Visser, Jeroen G. H. P. Verhoeven, Mirjam Laging, Sara J. Baart, Ingrid R. A. M. Mertens zur Borg, Dennis A. Hesselink, Anneke M. E. de Mik-van Egmond, Michiel G. H. Betjes, Madelon van Agteren, David Severs, Jacqueline van de Wetering, Robert Zietse, Michel J. Vos, Ido P. Kema, Marcia M. L. Kho, Marlies E. J. Reinders, Joke I. Roodnat
Publikováno v:
Transplant International, Vol 37 (2024)
Delayed graft function (DGF) after kidney transplantation heralds a worse prognosis. In patients with hyperoxaluria, the incidence of DGF is high. Oxalic acid is a waste product that accumulates when kidney function decreases. We hypothesize that res
Externí odkaz:
https://doaj.org/article/b6c0b924e66846c0820dde3f3d6e282b
Autor:
Nicolle H. R. Litjens, Amy C. J. van der List, Mariska Klepper, Derek Reijerkerk, Fréderique Prevoo, Michiel G. H. Betjes
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionOlder recipient age is associated with a significant decreased risk for rejection after kidney transplantation which is incompletely understood.MethodsIn a longitudinal study, circulating alloreactive T cells were assessed of young (≤45
Externí odkaz:
https://doaj.org/article/c6dee10092a64cacb8727de6e9c2b4ae